EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation

Anna Sominina, Daria Danilenko iD, Andrey B Komissarov, Maria Pisareva, Artem Fadeev iD, Nadezhda Konovalova, Mikhail Eropkin iD, Polina Petrova iD, Alyona Zheltukhina, Tamila Musaeva, Veronika Eder, Anna Ivanova und 16 weitere

Viruses · 2023

DOI: 10.3390/v15081780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Anna Sominina und 27 weiteren Autor:innen. Beteiligte Einrichtung: Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Influenza A Virus, H1N1 Subtype, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Health of Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic had a profound impact on influenza activity worldwide. However, as the pandemic progressed, influenza activity resumed. Here, we describe the influenza epidemic of high intensity of the 2022–2023 season. The epidemic had an early start and peaked in week 51.2022. The extremely high intensity of the epidemic may have been due to a significant decrease in herd immunity. The results of PCR-testing of 220,067 clinical samples revealed that the influenza A(H1N1)pdm09 virus dominated, causing 56.4% of positive cases, while A(H3N2) influenza subtype accounted for only 0.6%, and influenza B of Victoria lineage—for 34.3%. The influenza vaccine was found to be highly effective, with an estimated effectiveness of 92.7% in preventing admission with laboratory-confirmed influenza severe acute respiratory illness (SARI) cases and 54.7% in preventing influenza-like illness/acute respiratory illness (ILI/ARI) cases due to antigenic matching of circulated viruses with influenza vaccine strains for the season. Full genome next-generation sequencing of 1723 influenza A(H1N1)pdm09 viruses showed that all of them fell within clade 6B.1A.5.a2; nine of them possessed H275Y substitution in the NA gene, a genetic marker of oseltamivir resistance. Influenza A(H3N2) viruses belonged to subclade 3C.2a1b.2a.2 with the genetic group 2b being dominant. All 433 influenza B viruses belonged to subclade V1A.3a.2 encoding HA1 substitutions A127T, P144L, and K203R, which could be further divided into two subgroups. None of the influenza A(H3N2) and B viruses sequenced had markers of resistance to NA inhibitors. Thus, despite the continuing circulation of Omicron descendant lineages, influenza activity has resumed in full force, raising concerns about the intensity of fore coming seasonal epidemics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesInfluenza A Virus, H1N1 SubtypeCOVID-19HumansSeasonsVaccine EfficacyInfluenza A Virus, H3N2 SubtypePandemicsRussia

Stichwörter der Autor:innen

SARS CoV-2antigenic propertiesgenetic analysishospitalizationincidenceinfluenzamolecular detectionmonitoringsusceptibility to antivirals

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
  • National Research Center for Epidemiology and Microbiology Named after N.F. Gamaleya, 123098 Moscow, Russia.
  • Department of Infectious Diseases, First Pavlov State Medical University, 197022 Saint Petersburg, Russia.

ORCID-Profile: Daria Danilenko, Artem Fadeev, Mikhail Eropkin, Polina Petrova, Dmitry Lioznov

Förderung

  • The Ministry of Health of Russian Federation

Zitieren

APA

Sominina, A., Danilenko, D., Komissarov, A. B., Pisareva, M., Fadeev, A., Konovalova, N., Eropkin, M., Petrova, P., Zheltukhina, A., Musaeva, T., Eder, V., Ivanova, A., Komissarova, K., Stolyarov, K., Karpova, L., Smorodintseva, E., Dorosh, A., Krivitskaya, V., Kuznetzova, E., …, & Lioznov, D. (2023). Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation. Viruses. https://doi.org/10.3390/v15081780

Vancouver

Sominina A, Danilenko D, Komissarov AB, Pisareva M, Fadeev A, Konovalova N, et al. Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation. Viruses. 2023. doi:10.3390/v15081780

BibTeX
@article{Sominina2023,
  author = {Sominina, Anna and Danilenko, Daria and Komissarov, Andrey B and Pisareva, Maria and Fadeev, Artem and Konovalova, Nadezhda and Eropkin, Mikhail and Petrova, Polina and Zheltukhina, Alyona and Musaeva, Tamila and Eder, Veronika and Ivanova, Anna and Komissarova, Kseniya and Stolyarov, Kirill and Karpova, Ludmila and Smorodintseva, Elizaveta and Dorosh, Anna and Krivitskaya, Vera and Kuznetzova, Elena and Majorova, Victoria and Petrova, Ekaterina and Boyarintseva, Anastassia and Ksenafontov, Andrey and Shtro, Anna and Nikolaeva, Julia and Bakaev, Mikhail and Burtseva, Elena and Lioznov, Dmitry},
  title = {Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15081780}
}
Kostenlos starten →